(Q33448358)

26 July 2017

The International Bladder Cancer Bank: proposal for a new study concept (English)

1 reference

26 July 2017

5

Manolis Kogevinas

1 reference

26 July 2017

7

Guido Sauter

1 reference

26 July 2017

Peter J Goebell

1

1 reference

26 July 2017

Susan Groshen

2

1 reference

26 July 2017

Bernd J Schmitz-Dräger

3

1 reference

26 July 2017

Richard Sylvester

4

1 reference

26 July 2017

Núria Malats

6

1 reference

26 July 2017

H Barton Grossman

8

1 reference

26 July 2017

Fred Waldman

9

1 reference

26 July 2017

Richard J Cote

10

1 reference

26 July 2017

1 July 2004

1 reference

26 July 2017

1 reference

26 July 2017

22

1 reference

26 July 2017

277-284

1 reference

26 July 2017

4

1 reference

The breast cancer gene database: a collaborative information resource

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Identification of new polypeptide species (48–55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Molecular biology of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

p53 Expression Predicts Progression and Poor Survival in T1 Bladder Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Biological markers in superficial bladder tumors and their prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

p53 immunohistochemistry in bladder cancer. Combined analysis: a way to go?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Sample size considerations for the evaluation of prognostic factors in survival analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

What do we mean by validating a prognostic model?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Breast cancer prognostic factors: evaluation guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Prognostic factors: guidelines for investigation design and state of the art analytical methods

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

The First and Second International Workshops on Diagnostic and Prognostic Markers in Bladder Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Tissue microarray technology for high-throughput molecular profiling of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900175-3

7 January 2021

10.1016/S1078-1439(03)00175-3

Identifiers

DOI

1 reference

26 July 2017

1 reference